StartseiteMCPWorkbenchSkills
StartseiteWorkbenchBenachrichtigungenMein Bereich
llms.txt · MCP-AnleitungDatenschutz · Nutzungsbedingungen · Supportv1.8.0
  1. Startseite
  2. /Reaktion

Tetrabutylammonium Fluoride → (2S)-2-(1-(2-chloro-6-cyanophenyl)-1H-pyrazolo[3,4-d]pyrimidin-4-yloxy)-N-(5-chloropyridin-2-yl)-3-(2-hydroxyethoxy)propanamide

HRID 1098028
Notizen
Druckvorschau

Reaktionsgleichung

Reaktionsgleichung von HRID 1098028
[F-].C([N+](CCCC)(CCCC)CCCC)CCC.[Si]([O:36][CH2:37][CH2:38][O:39][CH2:40][C@H:41]([O:52][C:53]1[N:58]=[CH:57][N:56]=[C:55]2[N:59]([C:62]3[C:67]([C:68]#[N:69])=[CH:66][CH:65]=[CH:64][C:63]=3[Cl:70])[N:60]=[CH:61][C:54]=12)[C:42]([NH:44][C:45]1[CH:50]=[CH:49][C:48]([Cl:51])=[CH:47][N:46]=1)=[O:43])(C(C)(C)C)(C1C=CC=CC=1)C1C=CC=CC=1>C1COCC1>[Cl:70][C:63]1[CH:64]=[CH:65][CH:66]=[C:67]([C:68]#[N:69])[C:62]=1[N:59]1[C:55]2=[N:56][CH:57]=[N:58][C:53]([O:52][C@@H:41]([CH2:40][O:39][CH2:38][CH2:37][OH:36])[C:42]([NH:44][C:45]3[CH:50]=[CH:49][C:48]([Cl:51])=[CH:47][N:46]=3)=[O:43])=[C:54]2[CH:61]=[N:60]1
KomponentenVersuchsvorschriftAufarbeitungQuellen und NachweiseNotizen zur Reaktion

Komponenten

4

Edukt 2

HCID 2724141Tetrabutylammonium FluorideHCID 57504528(2S)-3-(2-(tert-butyldiphenylsilyloxy)ethoxy)-2-(1-(2-chloro-6-cyanophenyl)-1H-pyrazolo[3,4-d]pyrimidin-4-yloxy)-N-(5-chloropyridin-2-yl)propanamide

Produkt 1

HCID 46175431(2S)-2-(1-(2-chloro-6-cyanophenyl)-1H-pyrazolo[3,4-d]pyrimidin-4-yloxy)-N-(5-chloropyridin-2-yl)-3-(2-hydroxyethoxy)propanamideAusbeute 61,7 %

Reagenzien, Katalysatoren, Lösungsmittel 1

HCID 8028
Tetrahydrofuran
Lösungsmittel

Versuchsvorschrift

Tetrabutylammonium fluoride (1M in THF) (0.611 mL, 0.61 mmol) was added to (2S)-3-(2-(tert-butyldiphenylsilyloxy)ethoxy)-2-(1-(2-chloro-6-cyanophenyl)-1H-pyrazolo[3,4-d]pyrimidin-4-yloxy)-N-(5-chloropyridin-2-yl)propanamide (Intermediate AH1) in THF (5 mL) under nitrogen. The resulting mixture was stirred at ambient temperature for 1 hour. The reaction mixture was quenched with saturated NH4Cl (2 mL), diluted with DCM (25 mL) and poured through a phase separator. The organic phase was reduced to give a gum. This was purified by preparative HPLC (Waters XBridge Prep C18 OBD column, 5μ silica, 50 mm diameter, 150 mm length), using decreasingly polar mixtures of water (containing 0.1% formic acid) and MeCN as eluents. Fractions containing the desired compound were evaporated to dryness to afford (2S)-2-(1-(2-chloro-6-cyanophenyl)-1H-pyrazolo[3,4-d]pyrimidin-4-yloxy)-N-(5-chloropyridin-2-yl)-3-(2-hydroxyethoxy)propanamide (194 mg, 61.7%, 84% ee). 1H NMR (400 MHz, DMSO) δ 3.53 (2H, m), 3.70-3.58 (2H, m), 4.05 (1H, m), 4.13 (1H, m), 4.62 (1H, t), 5.95 (1H, s), 7.92-7.86 (2H, m), 8.06-8.00 (1H, m), 8.17 (1H, m), 8.19 (1H, m), 8.42-8.38 (1H, m), 8.61 (1H, s), 8.79 (1H, d), 11.21 (1H, s). m/z (ES+) (M+H)+=514; HPLC tR=2.10 min.

Aufarbeitung

  1. customThe reaction mixture was quenched with saturated NH4Cl (2 mL)
  2. additiondiluted with DCM (25 mL)
  3. additionpoured through a phase separator
  4. customto give a gum
  5. customThis was purified by preparative HPLC (Waters XBridge Prep C18 OBD column, 5μ silica, 50 mm diameter, 150 mm length)
  6. additionFractions containing the desired compound
  7. customwere evaporated to dryness

Quellen und Nachweise

ORD-Eintrag
ord-07ce8ac91af8420ebf7aa45e7ade326b
Quelldatensatz
uspto-grants-2012_03
DOI
10.6084/m9.figshare.5104873.v1
Patentnummer
US08143263B2

Notizen zur Reaktion

Wird geladen…

Auf dieser SeiteKomponentenVersuchsvorschriftAufarbeitungQuellen und NachweiseNotizen zur Reaktion